These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20933027)

  • 21. Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy.
    Hu M; Luo Q; Alitongbieke G; Chong S; Xu C; Xie L; Chen X; Zhang D; Zhou Y; Wang Z; Ye X; Cai L; Zhang F; Chen H; Jiang F; Fang H; Yang S; Liu J; Diaz-Meco MT; Su Y; Zhou H; Moscat J; Lin X; Zhang XK
    Mol Cell; 2017 Apr; 66(1):141-153.e6. PubMed ID: 28388439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of uterine estrogen signaling during early pregnancy in mice: an update.
    Robertshaw I; Bian F; Das SK
    J Mol Endocrinol; 2016 Apr; 56(3):R127-38. PubMed ID: 26887389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What's new in estrogen receptor action in the female reproductive tract.
    Hewitt SC; Winuthayanon W; Korach KS
    J Mol Endocrinol; 2016 Feb; 56(2):R55-71. PubMed ID: 26826253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear Receptor Signaling Atlas: Opening Access to the Biology of Nuclear Receptor Signaling Pathways.
    Becnel LB; Darlington YF; Ochsner SA; Easton-Marks JR; Watkins CM; McOwiti A; Kankanamge WH; Wise MW; DeHart M; Margolis RN; McKenna NJ
    PLoS One; 2015; 10(9):e0135615. PubMed ID: 26325041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma.
    Krakstad C; Tangen IL; Hoivik EA; Halle MK; Berg A; Werner HM; Ræder MB; Kusonmano K; Zou JX; Øyan AM; Stefansson I; Trovik J; Kalland KH; Chen HW; Salvesen HB
    Oncotarget; 2015 Sep; 6(29):28440-52. PubMed ID: 26308378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of corepressor alternative mRNA splicing by hormonal and metabolic signaling.
    Snyder CA; Goodson ML; Schroeder AC; Privalsky ML
    Mol Cell Endocrinol; 2015 Sep; 413():228-35. PubMed ID: 26166430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid hormone regulation of metabolism.
    Mullur R; Liu YY; Brent GA
    Physiol Rev; 2014 Apr; 94(2):355-82. PubMed ID: 24692351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical synthesis of the ATAD2 bromodomain.
    Creech GS; Paresi C; Li YM; Danishefsky SJ
    Proc Natl Acad Sci U S A; 2014 Feb; 111(8):2891-6. PubMed ID: 24516155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear receptor coactivators: master regulators of human health and disease.
    Dasgupta S; Lonard DM; O'Malley BW
    Annu Rev Med; 2014; 65():279-92. PubMed ID: 24111892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MED25 is a mediator component of HNF4α-driven transcription leading to insulin secretion in pancreatic beta-cells.
    Han EH; Rha GB; Chi YI
    PLoS One; 2012; 7(8):e44007. PubMed ID: 22952853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of thyroid hormone action.
    Brent GA
    J Clin Invest; 2012 Sep; 122(9):3035-43. PubMed ID: 22945636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acid ceramidase (ASAH1) represses steroidogenic factor 1-dependent gene transcription in H295R human adrenocortical cells by binding to the receptor.
    Lucki NC; Li D; Bandyopadhyay S; Wang E; Merrill AH; Sewer MB
    Mol Cell Biol; 2012 Nov; 32(21):4419-31. PubMed ID: 22927646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear receptor coregulators: modulators of pathology and therapeutic targets.
    Lonard DM; O'Malley BW
    Nat Rev Endocrinol; 2012 Oct; 8(10):598-604. PubMed ID: 22733267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wolbachia as an "infectious" extrinsic factor manipulating host signaling pathways.
    Negri I
    Front Endocrinol (Lausanne); 2011; 2():115. PubMed ID: 22654845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting transcription factor corepressors in tumor cells.
    Vaiopoulos AG; Kostakis ID; Athanasoula KCh; Papavassiliou AG
    Cell Mol Life Sci; 2012 Jun; 69(11):1745-53. PubMed ID: 22527719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis for a molecular allosteric control mechanism of cofactor binding to nuclear receptors.
    Osz J; Brélivet Y; Peluso-Iltis C; Cura V; Eiler S; Ruff M; Bourguet W; Rochel N; Moras D
    Proc Natl Acad Sci U S A; 2012 Mar; 109(10):E588-94. PubMed ID: 22355136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target.
    Fuchs M
    J Lipids; 2012; 2012():934396. PubMed ID: 22187656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternative mRNA splicing of corepressors generates variants that play opposing roles in adipocyte differentiation.
    Goodson ML; Mengeling BJ; Jonas BA; Privalsky ML
    J Biol Chem; 2011 Dec; 286(52):44988-99. PubMed ID: 22065574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pax6 represses androgen receptor-mediated transactivation by inhibiting recruitment of the coactivator SPBP.
    Elvenes J; Thomassen EI; Johnsen SS; Kaino K; Sjøttem E; Johansen T
    PLoS One; 2011; 6(9):e24659. PubMed ID: 21935435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene profiling of MTA1 identifies novel gene targets and functions.
    Ghanta KS; Li DQ; Eswaran J; Kumar R
    PLoS One; 2011 Feb; 6(2):e17135. PubMed ID: 21364872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.